NOV 04, 2016 10:00 AM PDT

Applying a multi-omics approach to tumor biomarker discovery - case studies

SPONSORED BY: Affymetrix, Affymetrix
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences; Yale School of Medicine
    Biography
      Dr. Yang Yang received her PhD degree from Nankai University. She is currently an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine.
    • Associate Professor of Pathology and Oncology; Johns Hopkins University School of Medicine
      Biography
        Dr. Tamara Lotan received her MD degree from the University of Chicago Pritzker School of Medicine. She is currently an Associate Professor of Pathology and Oncology at the Johns Hopkins University School of Medicine.
      • Professor of Pathology and Cell Biology; Columbia University
        Biography
          Dr. Antonia R. Sepulveda received her MD degree from University of Lisbon and her PhD degree from Baylor College of Medicine. She is Professor of Pathology and Cell Biology, Vice Chair for Translational Research, and Director, Division of Gastrointestinal Pathology at Columbia University.

        Abstract:
        DATE:  November 4, 2016
        TIME:  10:00am PT, 1:00pm ET

        How do you develop clinically relevant biomarkers?

        Systematic tumor profiling with multi-omics tools and rapid analytical validation is a powerful way to discover clinically relevant biomarkers and increase the probability of success. The parallel analysis of any combination of SNP, copy number variation, gene expression and regulation, protein expression, or cellular analysis enables rapid identification of the most robust biomarkers for impactful clinical application. The data from one type of analyte can provide biological validation for another, enhancing the diagnostic power and increasing confidence in the final biomarkers selected towards routine clinical use.

        During this webinar, three translational researchers will:
        • Discuss their experience applying a multi-omics approach to tumor profiling in ovarian, pancreatic, and prostate cancers 
        • Demonstrate the use of advanced technologies enabling rapid efficient biomarker discovery and validation at the DNA, RNA, protein, and cellular levels
        • Explain how the Affymetrix Tumor Profiling Grant has allowed them to undertake important projects aimed at improving cancer treatment that otherwise would not have come to fruition
        • Answer your questions live during the broadcast!
        Learning Objectives:
        • Understand how a multi-omics approach can increase confidence in cancer biomarker discovery
        • Gain exposure to new translational research tools for whole-genome and whole-transcriptome profiling

        Show Resources
        You May Also Like
        JUN 26, 2018 06:00 AM PDT
        C.E. CREDITS
        JUN 26, 2018 06:00 AM PDT
        Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
        MAY 24, 2018 09:30 AM PDT
        C.E. CREDITS
        MAY 24, 2018 09:30 AM PDT
        DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
        APR 27, 2018 10:00 AM PDT
        C.E. CREDITS
        APR 27, 2018 10:00 AM PDT
        DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
        AUG 15, 2018 08:00 AM PDT
        C.E. CREDITS
        AUG 15, 2018 08:00 AM PDT
        DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
        MAY 22, 2018 08:00 AM PDT
        C.E. CREDITS
        MAY 22, 2018 08:00 AM PDT
        DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
        APR 25, 2018 07:00 AM PDT
        C.E. CREDITS
        APR 25, 2018 07:00 AM PDT
        DATE: April 25, 2018TIME: 1500 CET, 10:00 a.m. EST, 7:00 a.m. PST Hematology and coagulation laboratories perform a wide range of routine and specialized tests, allowing clinicians to...
        Loading Comments...